West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 133,100 | 136,100 | 130,400 | 119,100 | 120,100 |
| Cost of Goods | 97,200 | 93,700 | 90,900 | 79,300 | 84,300 |
| Gross Profit | 35,900 | 42,400 | 39,500 | 39,800 | 35,800 |
| Operating Expenses | 26,100 | 27,300 | 26,800 | -7,700 | 29,200 |
| Operating Income | 10,000 | 15,800 | 13,600 | 47,800 | 6,900 |
| Interest Expense | 1,900 | 1,700 | 1,900 | 4,100 | 2,000 |
| Other Income | 1,200 | 900 | 1,000 | 1,900 | 700 |
| Pre-tax Income | 9,300 | 15,000 | 12,700 | 45,600 | 5,600 |
| Income Tax | 2,500 | 4,500 | 3,800 | 17,500 | 1,500 |
| Net Income Continuous | 6,800 | 10,500 | 8,900 | 28,100 | 4,100 |
| Net Income Discontinuous | -2,500 | -2,800 | -1,900 | N/A | N/A |
| Net Income | $4,300 | $7,700 | $7,000 | $17,100 | $4,100 |
| EPS Basic Total Ops | 0.07 | 0.13 | 0.12 | 0.30 | 0.07 |
| EPS Basic Continuous Ops | 0.12 | 0.18 | 0.15 | 0.48 | 0.07 |
| EPS Basic Discontinuous Ops | -0.05 | -0.05 | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | 0.07 | 0.13 | 0.12 | 0.30 | 0.07 |
| EPS Diluted Continuous Ops | 0.11 | 0.17 | 0.15 | 0.49 | 0.07 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.05 | -0.04 | N/A | N/A |
| EBITDA(a) | $18,200 | $24,100 | $21,400 | $54,600 | $14,700 |